Search by Drug Name or NDC

    NDC 00054-0427-20 flucytosine 250 mg/1 Details

    flucytosine 250 mg/1

    flucytosine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is FLUCYTOSINE.

    Product Information

    NDC 00054-0427
    Product ID 0054-0427_8e4eba6c-6315-436c-a5de-f5e37418ccf9
    Associated GPIs 11000020000105
    GCN Sequence Number 009542
    GCN Sequence Number Description flucytosine CAPSULE 250 MG ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 42560
    HICL Sequence Number 004131
    HICL Sequence Number Description FLUCYTOSINE
    Brand/Generic Generic
    Proprietary Name flucytosine
    Proprietary Name Suffix n/a
    Non-Proprietary Name flucytosine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name FLUCYTOSINE
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206550
    Listing Certified Through 2024-12-31

    Package

    NDC 00054-0427-20 (00054042720)

    NDC Package Code 0054-0427-20
    Billing NDC 00054042720
    Package 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0054-0427-20) / 1 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2017-10-17
    NDC Exclude Flag N
    Pricing Information N/A